1-8 of 8
Yan Xiong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multitarget kinase inhibitor olverembatinib is active and synergizes with BTK inhibitor acalabrutinib in preclinical models of Mantle Cell Lymphoma

Free
Bo Peng, Zhiyan Liang, Yan Xiong, Bingxing Wu, Yanqiu Ji, Zhou Yu, Dajun Yang, Yifan Zhai
Journal: Blood
Blood (2025) 146 (Supplement 1): 6814.
https://doi.org/10.1182/blood-2025-6814
Published: 2025
Journal Articles

Preclinical and clinical Study of olverembatinib in patients with myeloid/lymphoid neoplasms with FGFR1 rearrangement

Free
Wenzhi CAI, Yan Xiong, Xueqing Dou, Zhenfang Liu, Yu Zhu, Ying Wang, Chunmei Yang, Jiong Hu, Miao Miao, Lihua Sun, Chen Chunyan, Xiuzhi Deng, Xiaolu Zhu, Xiaosheng Fang, Xiaojing Yan, Guoqiang Lin, Chenglu Yuan, Xingxia Zhang, Depei Wu, Suning Chen
Journal: Blood
Blood (2025) 146 (Supplement 1): 1979.
https://doi.org/10.1182/blood-2025-1979
Published: 2025
Journal Articles

Multi-omics profiling of the gut Microbiota–Metabolism–Immunity axis reveals predictive biomarkers of treatment response and survival in diffuse large B-cell lymphoma

Free
Lixia Sheng, Changyu Jin, Huijie Hu, Yanli Lai, Huiying Qiu, Shasha You, Jiaping Wang, Shuyan Wang, Yan Xiong, Li Hu, Kaihong Xu, Ping Zhang, Yongcheng Sun, Lieguang Chen, Shanhao Tang, Xiao Wu, Yi Zhang, Qitian Mu, Tongyu Li, Xinjun Wang, Guifang Ouyang
Journal: Blood
Blood (2025) 146 (Supplement 1): 3533.
https://doi.org/10.1182/blood-2025-3533
Published: 2025
Journal Articles

Olverembatinib (HQP1351) in Combination with Lisaftoclax Overcomes Venetoclax Resistance in Preclinical Model of Acute Myeloid Leukemia (AML)

Free
Yan Xiong, Zhiyan Liang, Ping Min, Bingxing Wu, Huidan Yu, Dajun Yang, Yifan Zhai
Journal: Blood
Blood (2024) 144 (Supplement 1): 5777.
https://doi.org/10.1182/blood-2024-202699
Published: 2024
Journal Articles

Neutralizing Antibody Responses in Patients with Hematological Malignancies after Omicron Infection: A Multicenter, Prospective Cohort Study in China

Free
Li Jun, Yi Liu, Xia Wei, Zhanshu Liu, Zailiang Yang, Ling Liu, Meiyu Zhou, Guofa Xu, Lanting Chen, Yao Ding, Haike Lei, Zailin Yang, Shuang Chen, Xiaomei Zhang, Yifeng Tang, Yan Xiong, Jueyin Liu, Dehong Huang, Chunyan Xiao, Jun Liu, Tao Yang, Ying Xiang, Qiying Li, Yingyu Nan, Jieping Li, Yong Zhang, Yongzhong Wu, Yao Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 2557.
https://doi.org/10.1182/blood-2023-179113
Published: 2023
Journal Articles

Olverembatinib (HQP1351) Enhances Antitumor Effects of Chemotherapy in Philadelphia Chromosome-Positive (Ph⁺) Acute Lymphoblastic Leukemia (ALL)

Free
Eric Liang, Ping Min, Yan Xiong, Bingxing Wu, Huidan Yu, Dajun Yang, Yifan Zhai
Journal: Blood
Blood (2023) 142 (Supplement 1): 5882.
https://doi.org/10.1182/blood-2023-189315
Published: 2023
Journal Articles

Increased Prevalence of Neoplasms In Patients Diagnosed with Common Variable Immunodeficiency.

Free
William J Grossman, MD, PhD, Patrick O Bonnet, PharmD, MS, Yan Xiong, MS
Journal: Blood
Blood (2010) 116 (21): 1531.
https://doi.org/10.1182/blood.V116.21.1531.1531
Published: 2010
Journal Articles

The heparin-binding site of antithrombin is crucial for antiangiogenic activity

Free
Weiqing Zhang, Richard Swanson, Gonzalo Izaguirre, Yan Xiong, Lester F. Lau, Steven T. Olson
Journal: Blood
Blood (2005) 106 (5): 1621–1628.
https://doi.org/10.1182/blood-2005-02-0547
Published: 2005